Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Athenex Inc (ATNX)

Athenex Inc (ATNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Athenex Inc 1001 Main Street Suite 600 Buffalo NY 14203 USA

www.athenex.com P: 716-427-2950

Description:

Athenex, Inc. is a clinical stage biopharmaceutical company. It engaged in the discovery and development of drugs for the treatment of cancer. The company's platform including an Oncology Innovation Platform, a Commercial Platform and a Global Supply Chain Platform. It operates primarily in Buffalo and Clarence, New York, Cranford, New Jersey, Houston, Texas, Chicago, Illinois, Hong Kong and Taipei Taiwan. Athenex, Inc. is based in Buffalo, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,759
Enterprise Value, $K 2,199
Shares Outstanding, K 8,663
Annual Sales, $ 102,820 K
Annual Net Income, $ -103,430 K
Last Quarter Sales, $ 8,050 K
Last Quarter Net Income, $ -34,180 K
60-Month Beta 1.36
% of Insider Shareholders 9.20%
% of Institutional Shareholders 30.48%
Float, K 7,866
% Float 90.80%
Short Volume Ratio 0.47

Growth:

1-Year Return -97.97%
3-Year Return -99.91%
5-Year Return -99.94%
5-Year Revenue Growth 170.29%
5-Year Earnings Growth 68.19%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -3.38 on 03/20/23
Latest Earnings Date 05/30/23
Earnings Per Share ttm -15.58
EPS Growth vs. Prev Qtr -20.71%
EPS Growth vs. Prev Year 41.72%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 02/15/23

ATNX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -44.44%
Profit Margin % -100.59%
Debt/Equity 0.00
Price/Sales 0.02
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -3.07
Interest Coverage -2.82
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar